OS Therapies Company Insiders
| OSTX Stock | 5.16 0.05 0.98% |
OS Therapies employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Break down of OS Therapies' management performance can provide insight into the company performance.
OSTX |
OS Therapies Management Team Effectiveness
Non Current Assets Total is likely to rise to 8,906 in 2024, whereas Total Assets are likely to drop slightly above 598.8 K in 2024. OS Therapies' management efficiency ratios could be used to measure how well OS Therapies manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to drop to about 16.5 M in 2024
OS Therapies Workforce Comparison
OS Therapies Incorporated is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 98,071. OS Therapies adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
OS Therapies Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OS Therapies insiders, such as employees or executives, is commonly permitted as long as it does not rely on OS Therapies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, OS Therapies insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mckean-dieser Avril Suzette over two months ago Insider Trading | ||
Mckean-dieser Avril Suzette over two months ago Insider Trading | ||
Ciccio John over three months ago Acquisition by Ciccio John of 266306 shares of OS THERAPIES at 75000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Ciccio John over three months ago Acquisition by Ciccio John of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Acevedo Christopher P. over three months ago Disposition of tradable shares by Acevedo Christopher P. of OS THERAPIES subject to Rule 16b-3 |
OS Therapies Notable Stakeholders
An OS Therapies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OS Therapies often face trade-offs trying to please all of them. OS Therapies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OS Therapies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Paul MPH | President Founder | Profile | |
| Jack Doll | Chief Staff | Profile | |
| Robert Petit | Chief Officer | Profile | |
| Christopher Acevedo | Chief Officer | Profile | |
| Gerald Commissiong | Chief Officer | Profile |
About OS Therapies Management Performance
The success or failure of an entity such as OS Therapies often depends on how effective the management is. OS Therapies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OSTX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OSTX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OS Therapies is entity of United States. It is traded as Stock on NYSE MKT exchange.
Please note, the imprecision that can be found in OS Therapies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OS Therapies Incorporated. Check OS Therapies' Beneish M Score to see the likelihood of OS Therapies' management manipulating its earnings.
OS Therapies Workforce Analysis
Traditionally, organizations such as OS Therapies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OS Therapies within its industry.OS Therapies Manpower Efficiency
Return on OS Therapies Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.6M | |
| Net Loss Per Executive | 1.6M |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.